Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.75
+0.13008.02%
Post-market: 1.820.0700+4.00%18:42 EST
Volume:692.37K
Turnover:1.21M
Market Cap:67.31M
PE:-2.75
High:1.82
Open:1.63
Low:1.63
Close:1.62
52wk High:4.34
52wk Low:1.41
Shares:38.46M
Float Shares:37.12M
Volume Ratio:1.19
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6370
EPS(LYR):-0.8920
ROE:-261.72%
ROA:-86.79%
PB:11.39
PE(LYR):-1.96

Loading ...

Gain Therapeutics Showcases Allosteric Small Molecule Therapies at J.P. Morgan Healthcare Conference Week

Reuters
·
Jan 07

Gain Therapeutics Announces Announces Conference Participation During J.p. Morgan Healthcare Conference Week

THOMSON REUTERS
·
Jan 07

Gain Therapeutics Reports Positive Phase 1b Results for GT-02287 in Parkinson's Disease

Reuters
·
Jan 06

Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287

GlobeNewswire
·
Jan 06

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025

Gain Therapeutics Hosts Virtual KOL Event Showcasing GT-02287 Biomarker Data for Parkinson’s Disease

Reuters
·
Dec 19, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
Dec 18, 2025

Gain Therapeutics Reports First Reduction of GluSph in Parkinson’s Patients with GT-02287 in Phase 1b Trial

Reuters
·
Dec 18, 2025

Gain Therapeutics Inc - Shows Reduction in Gcase Substrate for Pd

THOMSON REUTERS
·
Dec 18, 2025

Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint From Its Phase 1B Clinical Study of GT-02287 in People With Parkinson’s Disease

THOMSON REUTERS
·
Dec 18, 2025

LIVE MARKETS-Stocks gain, yields little changed after Fed's hawkish cut

Reuters
·
Dec 11, 2025

Gain Therapeutics Announces New Stock Offering Program

TIPRANKS
·
Nov 29, 2025

BRIEF-Gain Therapeutics Files Prospectus For $35.5 Million Stock Sale - SEC Filing

Reuters
·
Nov 29, 2025

Gain Therapeutics Inc - Files Prospectus for $35.5 Mln Stock Sale - SEC Filing

THOMSON REUTERS
·
Nov 29, 2025

Gain Therapeutics Unveils Preclinical Data Showing GT-02287 Boosts Mitochondrial Function in Parkinson’s Models

Reuters
·
Nov 20, 2025

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GlobeNewswire
·
Nov 20, 2025

Positive Outlook for Gain Therapeutics: Promising Clinical Trial Results and Stable Financial Health Drive Buy Rating

TIPRANKS
·
Nov 16, 2025

Gain Therapeutics Reports Continued Progress Amid Financial Challenges

TIPRANKS
·
Nov 13, 2025

Gain Therapeutics Q3 EPS $(0.15) Beats $(0.16) Estimate

Benzinga
·
Nov 12, 2025

Gain Therapeutics Q3 EPS USD -0.15

THOMSON REUTERS
·
Nov 12, 2025